Litcius/Paper detail

Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trial

Markus P. Schlaich, M Bellet, Michael A. Weber, Parisa Danaietash, George L. Bakris, John M. Flack, Roland F. Dreier, Mouna Sassi-Sayadi, Lloyd Haskell, Krzysztof Narkiewicz, Ji‐Guang Wang, Christopher M. Reid, Markus P. Schlaich, Ivor Katz, Andrew E. Ajani, Sinjini Biswas, Murray Esler, Grahame J. Elder, Simon D. Roger, David Colquhoun, John G. Mooney, Tine De Backer, Alexandre Persu, Martin Chaumont, Jean-Marie Krzesinski, Thomas Vanassche, Ginette Girard, Lew Pliamm, Ernesto L. Schiffrin, Fatima Merali, George K. Dresser, Michel Vallée, Shivinder Jolly, S. P. Chow, Ji‐Guang Wang, Jianjun Mu, Jing Yu, Hong Yuan, Yingqing Feng, Xin Zhang, Jianhong Xie, Ling Lin, Miroslav Souček, J Widimský, Renata Cífková, J. Václavík, Martin Ullrych, Martin Lukáč, Ivan Rychlík, Thomas Guldager Lauridsen, Ilkka Kantola, Jyrki Taurio, Olavi Ukkola, Olivier Ormezzano, Philippe Gosse, Michel Azizi, Pierre‐Yves Courand, Pascal Delsart, Jean Michel Tartiere, Felix Mahfoud, Roland E. Schmieder, Johannes Stegbauer, Philipp Lurz, Michael Koziolek, Christian Ott, Nicole Toursarkissian, Konstantinos Tsioufis, K. Kyfnidis, Athanasios Manolis, Sotirios Patsilinakos, Pantelis Zebekakis, Apostolos Karavidas, Pall Denes, Katalin Bezzegh, Marianna Zsom, László Kovács, Yehonatan Sharabi, Mazen Elias, Ivetta Sukholutsky, Chaim Yosefy, Irina Kenis, Shaul Atar, Massimo Volpe, Muiesan Maria Lorenza, Stefano Taddei, Guıdo Grassı, Franco Veglio, Jung‐Woo Son, Jang‐Young Kim, Joong-Il Park, Chang Hoon Lee, Hae‐Young Lee, Rasa Raugalienė, Jolanta Elena Marcinkeviciene, Roma Kavaliauskiene, Jaap Deinum, Abraham A. Kroon, Bert‐Jan H. van den Born, Andrzej Januszewicz, Andrzej Tykarski

2022The Lancet228 citationsDOIOpen Access PDF

Topics & Concepts

MedicinePlaceboBlood pressureAmbulatory blood pressureDiureticClinical endpointEndothelin receptor antagonistInternal medicineRandomized controlled trialEndothelin receptorAlternative medicinePathologyReceptorNitric Oxide and Endothelin EffectsBlood Pressure and Hypertension StudiesSodium Intake and Health
Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trial | Litcius